Verzending 24–48 u • Levering in de hele EU • Veilige chemieverpakking
Competitive inhibitor of ATP binding to the catalytic domain of tyrosin kinases. Exceptional are the insulin receptor tyrosin kinase and the serin-/threonin specific proteases, which will not be inhibited by genistein. An additional, tyrosin kinase independent, effect of genistein is the inhibition of topoisomerases I and II.
Working concentration: 10-100 µM
| Assay (HPLC) | ≥98 % |
| Heavy metals | ≤0,001 % |
| Loss on drying | ≤1,0 % |


![Ethyl 6-bromoimidazo[1,2-a]pyrimidine-2-carboxylate, 95%, 5g Ethyl 6-bromoimidazo[1,2-a]pyrimidine-2-carboxylate, 95%, 5g](https://d2j6dbq0eux0bg.cloudfront.net/images/88473019/4769797123.png)






![methyl 3H-imidazo[4,5-b]pyridine-5-carboxylate, 500mg methyl 3H-imidazo[4,5-b]pyridine-5-carboxylate, 500mg](https://d2j6dbq0eux0bg.cloudfront.net/images/88473019/4782497157.png)
Verzending 24–48 u • Levering in de hele EU • Veilige chemieverpakking
